Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Pain Management Therapeutics Market to Cross US$ 83 Billion by 2024

Market Research Engine
Posted on: 04 Oct 16
Pain Management Therapeutics Market to Cross US$ 83 Billion by 2024

New York, October 04: Market Research Engine has published a new report titled as “Pain Management Therapeutics Market by Therapeutics Analysis (Antidepressants, Anesthetics, Anticonvulsants, Opioids (Oxycodones, Hydrocodones, Tramadol), Antimigraine Agents, Other Non-narcotic Analgesic); by Indication Analysis (Migraine, Cancer Pain, Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Post-operative Pain) - Global Industry Analysis and Forecast 2016 - 2024”

How Big is The Pain Management Therapeutics Market?

The pain management therapeutics market is expected to exceed more than US$ 83 Billion by 2024; Growing at a CAGR of more than 3.5% in the given forecast period.

Download Free Sample Report:

Pain management is one of the branch of medicine which utilizes an inter punitive approach for improving the superiority and easing the suffering of life of persons who are living with the chronic pain. The usual pain management group consists of clinical psychologists, clinical nurse specialists, physician assistants, occupational therapists, physiotherapists, pharmacists and medical practitioners. Market analyst proposes that almost 20% of world’s population currently suffers from chronic pain. Factors that are increasing number of surgeries, changing lifestyle, increasing geriatric population and increasing prevalence of chronic diseases are responsible for growth in new patients every year.

The major driving factors of pain management therapeutics market are as follows:

Approving health care reforms and regulatory scenario
Increasing approval of pain management therapeutics between end users
Increasing in geriatric population with high risk of different diseases
Growing frequency of chronic pain disorders

The restraining factors of pain management therapeutics market are as follows:

Enduring pain relief from medical devices, alternative therapies and surgical procedures
Prescription drug exploitation
Exclusive rights expiry of entry of generics and key drugs

Browse Full Report:

The pain management therapeutics market is segmented on the lines of its therapeutics, indication and regional. Based on therapeutics segmentation it covers antimigraine agents, non steroidal anti inflammatory drugs, anesthetics, antidepressants, anticonvulsants, opioids and other non narcotic analgesic. Opioidsis further segmented into tramadol, hydrocodones, oxycodaones and others such as methadone, meperidine, fentanyl, codeine, morphine. Based on indication segmentation the pain management therapeutics market covers cancer pain, post operative pain, migraine, arthritic pain, chronic back pain, fibromyalgia and neuropathic pain. The pain management therapeutics marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for pain management therapeutics and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2024.

3) Identifications of new market opportunities and targeted promotional plans for pain management therapeutics.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.



The scope of the report includes a detailed study of global and regional markets for pain management therapeutics with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, AstraZeneca, Depomed, Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Limited. Company profile includes assign such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide buyers with a snapshot of the industry’s most influential players.

The Pain management therapeutics Market has been segmented as below:  

By Therapeutics Analysis

Antimigraine agents
Non steroidal anti inflammatory drugs
    Others (Methadone, Meperidine, Fentanyl, Codeine, Morphine)
Other non narcotic analgesic

By Indication Analysis

Cancer pain
Post operative pain
Arthritic pain
Chronic back pain
Neuropathic pain

By Regional Analysis

North America
Rest of the World

Reasons to Buy this Report:

1) Obtain the most up to date information available on all  pain management therapeutics market globally.

2) Identify growth segments and opportunities in the industry.

3) Facilitate decision making on the basis of strong historic and forecast of pain management therapeutics data.

4) Assess your competitor’s refining portfolio and its evolution.

For more information:

Editor's Details

John Bay
Market Research Engine

Last updated on: 04/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.